Korea’s 7 botanical drugs developed under Pharmaceutical Affairs Law: KPMA

Published: 2013-01-18 06:58:00

Updated: 2013-01-18 06:58:00

The Korea Pharmaceutical Manufacturers Association (KPMA) said Wednesday that the nation’s 7 botanical drugs, including Dong-A’s Stillen and SK Chemicals’ Joins, are prescription drugs developed through a series of clinical trials in accordance with the provisions of the Pharmaceutical Affairs La...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK